Cutler Group LP Ptc Therapeutics, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$29.83 - $46.51 $3,967 - $6,185	-133 Reduced 32.68%	274 $9,000
Q3 2018 Nov 07, 2018	BUY	$33.9 - $47.77 $4,508 - $6,353	133 Added 48.54%	407 $19,000
Q2 2018 Aug 10, 2018	SELL	$25.7 - $47.88 $64,250 - $119,700	-2,500 Reduced 90.12%	274 $9,000
Q1 2018 May 11, 2018	BUY	$17.46 - $32.59 $20,480 - $38,228	1,173 Added 73.27%	2,774 $75,000
Q4 2017 Jan 17, 2018	SELL	$15.14 - $20.89 $941,480 - $1.3 Million	-62,185 Reduced 97.49%	1,601 $26,000
Q3 2017 Oct 17, 2017	BUY	$16.81 - $21.61 $1.07 Million - $1.38 Million	63,786	63,786 $1.28 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.